Science Explorer Back to mapMap

Most cited papers from European Patients Forum

What are the most cited papers from European Patients Forum?

The most cited paper from European Patients Forum is "EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes" (David Haerry, Cordula Landgraf, Kay Warner et al., 2018), with 83 citations. Next come "EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D" (73) and "Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol" (52).

Showing 32 of 32 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes David Haerry, Cordula Landgraf, Kay Warner et al. · Frontiers in Medicine Open access 17 Aug 2018 83
2 EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D Kay Warner, Wolf See, David Haerry et al. · Frontiers in Medicine Open access 9 Oct 2018 73
3 Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol Marta Ballester, Carola Orrego, Monique Heijmans et al. · BMJ Open Open access 2020 52
4 EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials Ingrid Klingmann, Andrea Heckenberg, Kay Warner et al. · Frontiers in Medicine Open access 7 Sep 2018 37
5 Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era Maggie Christine Walter, Claudia A. Chiriboga, Tina Duong et al. · Journal of Neuromuscular Diseases Open access 24 Feb 2021 29
6 Evolution of reported patient and public involvement over time in randomised controlled trials in major medical journals and in their protocols: meta-epidemiological evaluation Alice Vanneste, Io Wens, Peter Sinnaeve et al. · BMJ Open access 10 Apr 2025 27
7 Health-care improvements in a financially constrained environment Inger Ekman, Reinhard Busse, Ewout van Ginneken et al. · The Lancet Open access Feb 2016 24
8 The perspectives of patients and their caregivers on self-management interventions for chronic conditions: a protocol for a mixed-methods overview Ena Niño de Guzmán, Laura Martínez García, Ana Isabel González‐González et al. · F1000Research Open access 18 Feb 2020 22
9 Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study Ann‐Kristin Porth et al. · Diabetic Medicine Open access 28 Nov 2023 20
10 The Role of Community Health Workers Within the Continuum of Services for HIV, Viral Hepatitis, and Other STIs Amongst Men Who Have Sex with Men in Europe Nicolas Lorente, Nigel Sherriff, Oksana Panochenko et al. · Journal of Community Health Open access 31 Jul 2020 17
11 Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment? Juliette Plun-Favreau, Kaisa Immonen-Charalambous, Lotte Steuten et al. · Public Health Genomics Open access 2016 13
12 Recommended methodologies for clinical investigations of high-risk medical devices—Conclusions from the European Union CORE–MD Project Alan G. Fraser et al. · The Lancet Regional Health - Europe Open access 17 Sep 2025 12
13 Innovation of Medical Products: The Evolution of Regulatory Science, Research, and Education Per Spindler, Karin Friis Bach, Merete Schmiegelow et al. · Therapeutic Innovation & Regulatory Science 12 Aug 2015 11
14 Medicines Adaptive Pathways to Patients: Why, When, and How to Engage? Hans‐Georg Eichler, Nicola Bedlington, Mathieu Boudes et al. · Clinical Pharmacology & Therapeutics Open access 14 Jun 2018 10
15 Identifying most important contextual factors for the implementation of self-management interventions: A Delphi study Janneke Noordman, Monique Heijmans, Rune Poortvliet et al. · Patient Education and Counseling Open access 7 Jun 2023 5
16 Assessing the Involvement of the Patient Community in European Commission Co-Funded Health Projects L. Sanna · Journal of Ambulatory Care Management Jul 2010 5
17 Toward a Harmonized Health Technology Assessment Framework for Digital Health Technologies in Europe Emmanouil Tsiasiotis, Fruzsina Mezei, Rossella Di Bidino et al. · Value in Health Open access 22 Dec 2025 3
18 Conformity Between Values and EU Legal Requirements Regarding an AI Clinical Decision Support System (AI-CDSS) for Improved Cardiovascular Risk Management (DECIDE) María Villalobos‐Quesada, de Graaf, André Krom et al. · SSRN Electronic Journal PreprintOpen access 2025 2
19 Has the pandemic enhanced and sustained digital health-seeking behaviour? A big data interrupted time-series analysis of Google Trends Robin van Kessel, Ilias Kyriopoulos, Brian Li Han Wong et al. · medRxiv PreprintOpen access 30 Jul 2022 2
20 Enhancing Patient-Centered Health Technology Assessment: A Modified Delphi Panel for PICOS Scoping in Spinal Muscular Atrophy Emanuele Arcà, Adele Barlassina, Adaeze Eze et al. · Journal of Market Access & Health Policy Open access 19 Jan 2026 1
21 More than just a voice: how the OECD’s Patient-Reported Indicator Surveys (PaRIS) Patient Advisory Panel drives action and results Rebecca Barlow-Noone, Elizabeth Deveny, Cajsa Lindberg et al. · IJQHC Communications Open access 11 Oct 2025 1
22 Development of an Updated, Standardized, Patient-Centered Outcome Set for Lung Cancer Belle Hadewijch de Rooij, Corina J. G. van den Hurk, Veerle Smaardijk et al. · SSRN Electronic Journal PreprintOpen access 2022 1
23 Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance Luis Correia Pinheiro, Amanda C. Langston, Marie Orre et al. · Clinical Pharmacology & Therapeutics Open access 13 Aug 2026 0
24 Lived experience and global health architecture reform: from afterthought to cornerstone Johanna Ralston, Lavanya Vijayasingham, Chikhulupiliro Stanley Ng’ombe et al. · The Lancet Global Health Open access 7 Jul 2026 0
25 Regulatory research priorities for AI use in the medicine lifecycle: a European perspective with global relevance Luis Pinheiro, Amanda Langston, Marie Orre et al. · Zenodo (CERN European Organization for Nuclear Research) Open access 13 Aug 2026 0
26 The Evolving Role of Patient Organisations in HTA Valentina Strammiello, François Houÿez, Julien Delaye et al. · Health informatics Book chapterOpen access 2026 0
27 European Union: Patient Involvement Model in HTA Under the European HTA Regulation Margaret Galbraith, Valentina Strammiello, Anne Willemsen · Health informatics Book chapterOpen access 2026 0
28 European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data Rosa Gonzalez‐Quevedo, Juan García Burgos, Marco Greco et al. · British Journal of Clinical Pharmacology Open access 5 Nov 2025 0
29 Global Heart Hub report: ‘unite for change in transforming cardiovascular care for people living with multiple conditions’ Jennifer L. Jones, Phil Collis, Joanna Ten-Kate et al. · European Journal of Cardiovascular Nursing Open access Oct 2025 0
30 Is My LLM Application Considered a Medical Device under the MDR? Jessica D. Workum, Sade Krijgsman, Ildiko Vajda et al. · SSRN Electronic Journal PreprintOpen access 2025 0
31 Empowering Patients in Health Technology Assessment: The European Capacity Building for Patients (EUCAPA) Initiative Milena Muehler, Silke Siebert, Petra Schnell‐Inderst et al. · Das Gesundheitswesen Dec 2024 0
32 EPF Universal Health Coverage - Access Campaign 2017 Louette, Laurent · European Society of Radiology Open access Mar 2017 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.